Cooper Companies (The)

When researching Cooper Companies (The), analysts typically begin with its Health Care sector positioning and Health Care Supplies industry dynamics. CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.

The company reports trailing twelve-month revenue of $654.30M and net income of $130.80M. Key metrics include a return on equity of 1.6%, a debt-to-equity ratio of 0.49.

FINOTAUR provides free research summaries, news aggregation, and fundamentals for COO to support both active traders and long-term investors.